Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D Intake
NCT01994018 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-04-29
Summary
The correlation between relapses in MS and vitamin D intake will be examined.
Conditions
Sponsors & Collaborators
-
OSF Healthcare System
lead OTHER
Principal Investigators
-
Reuben M Valenzuela, MD · OSF Healthcare System
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- United States
Study Locations
More Related Trials
-
Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS)
NCT00940719 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis
NCT03552211 ·Status: UNKNOWN
-
Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis
NCT05340985 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients
NCT01005095 ·Status: TERMINATED ·Phase: PHASE4
-
MS Relapses During COVID-19 Pandemic
NCT04858763 ·Status: COMPLETED
-
Observational Trial Evaluating Elevated Factor VIII Related Labs as a Biomarker for Incomplete Relapse Recovery
NCT05926167 ·Status: UNKNOWN
-
Vitamine D in Multiple Sclerosis
NCT01768039 ·Status: UNKNOWN ·Phase: PHASE3
-
High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients
NCT02696590 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients
NCT03610139 ·Status: UNKNOWN ·Phase: NA
-
Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in Relapse
NCT01986998 ·Status: COMPLETED ·Phase: PHASE4
-
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
NCT00997438 ·Status: COMPLETED ·Phase: PHASE1
-
Relationship Between the Nutritional Habits and Relapsing and Disability Rates in Patient With Multiple Sclerosis.
NCT04110171 ·Status: UNKNOWN
-
Regulation of Lipid Metabolism in Autoimmune Disease: Multiple Sclerosis
NCT04053374 ·Status: UNKNOWN
-
Phototherapy in Persons With Multiple Sclerosis
NCT02365259 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis (MS) Relapses
NCT00984984 ·Status: UNKNOWN ·Phase: PHASE3
-
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
NCT00919217 ·Status: TERMINATED
-
Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis
NCT03302442 ·Status: COMPLETED
-
The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment
NCT01067573 ·Status: COMPLETED
-
COVID-19 and Multiple Sclerosis Disease Modifying Therapies
NCT04863586 ·Status: UNKNOWN
-
Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS)
NCT00981084 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS)
NCT01440062 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Importance of Glucose Regulation in Relapsing MS
NCT03004079 ·Status: UNKNOWN
-
Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
NCT02133664 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly
NCT01198132 ·Status: COMPLETED ·Phase: PHASE2
-
Preventive Use of COrticosteroids During the Post-Partum in Relapsing MS Patients (COPP-MS)
NCT03917589 ·Status: COMPLETED